Brachytherapy I-125, distant conformal radiotherapy, HIFU-ablation in treatment for localized prostate cancer: a retrospective comparison of relapse-free survival
The article deals with comparison of biochemical relapse-free survival (BRFS) in localized stage I-II prostate cancer patients after external-beam 3D conformal or intensity-modulated radiation therapy (EBRT), brachytherapy I-125 (BT) or high intensity focused ultrasound ablation (HIFU). It was found that BT was superior to HIFU by BRFS. Routine use of HIFU technology is inappropriate before getting satisfactory evidence from randomized trials.